Microvesicles released by apoptotic human neutrophils suppress proliferation and IL-2/IL-2 receptor expression of resting T helper cells
Standard
Microvesicles released by apoptotic human neutrophils suppress proliferation and IL-2/IL-2 receptor expression of resting T helper cells. / Shen, Guifen; Krienke, Stefan; Schiller, Petra; Nießen, Anna; Neu, Susanne; Eckstein, Volker; Schiller, Martin; Lorenz, Hanns-Martin; Tykocinski, Lars-Oliver.
In: EUR J IMMUNOL, Vol. 47, No. 5, 05.2017, p. 900-910.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Microvesicles released by apoptotic human neutrophils suppress proliferation and IL-2/IL-2 receptor expression of resting T helper cells
AU - Shen, Guifen
AU - Krienke, Stefan
AU - Schiller, Petra
AU - Nießen, Anna
AU - Neu, Susanne
AU - Eckstein, Volker
AU - Schiller, Martin
AU - Lorenz, Hanns-Martin
AU - Tykocinski, Lars-Oliver
N1 - © 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
PY - 2017/5
Y1 - 2017/5
N2 - Membrane-coated microvesicles (MVs) have been identified as important mediators in intercellular communication. During the process of apoptosis, dying cells dynamically release MVs. Neutrophils are the most abundant type of leukocytes in the circulation. Due to their very short lifespan, it is likely that they are the source of large amounts of apoptotic cell-derived MVs. Here, we show that MVs released by apoptotic human polymorphonuclear neutrophils (apoPMN-MVs), but not the apoptotic neutrophils themselves, selectively suppress the proliferation of CD25 (IL-2Rα)neg CD127 (IL-7Rα)pos Th cells in a dose-dependent manner. In contrast, the proliferation of total T cells is not affected by MVs. Importantly, apoPMN-MVs suppress the secretion of IL-2 as well as the expression of and signaling via the IL-2 receptor (IL-2R) by CD25neg CD127pos Th cells. Addition of IL-7 strongly reduced the suppression of T-cell proliferation by MVs and the addition of IL-2 completely abrogated the suppressive effect. Thus, apoPMN-MVs suppressed a subset of Th cells by downregulating IL-2 and IL-2R expression and signaling. This may represent an important mechanism to prevent the activation and expansion of resting T cells in the absence of sufficient cytokine stimulation, and thereby maintaining immune tolerance.
AB - Membrane-coated microvesicles (MVs) have been identified as important mediators in intercellular communication. During the process of apoptosis, dying cells dynamically release MVs. Neutrophils are the most abundant type of leukocytes in the circulation. Due to their very short lifespan, it is likely that they are the source of large amounts of apoptotic cell-derived MVs. Here, we show that MVs released by apoptotic human polymorphonuclear neutrophils (apoPMN-MVs), but not the apoptotic neutrophils themselves, selectively suppress the proliferation of CD25 (IL-2Rα)neg CD127 (IL-7Rα)pos Th cells in a dose-dependent manner. In contrast, the proliferation of total T cells is not affected by MVs. Importantly, apoPMN-MVs suppress the secretion of IL-2 as well as the expression of and signaling via the IL-2 receptor (IL-2R) by CD25neg CD127pos Th cells. Addition of IL-7 strongly reduced the suppression of T-cell proliferation by MVs and the addition of IL-2 completely abrogated the suppressive effect. Thus, apoPMN-MVs suppressed a subset of Th cells by downregulating IL-2 and IL-2R expression and signaling. This may represent an important mechanism to prevent the activation and expansion of resting T cells in the absence of sufficient cytokine stimulation, and thereby maintaining immune tolerance.
KW - Apoptosis
KW - Cell Communication
KW - Cell Proliferation/drug effects
KW - Cell-Derived Microparticles/immunology
KW - Humans
KW - Immune Tolerance
KW - Interleukin-2/genetics
KW - Interleukin-2 Receptor alpha Subunit/genetics
KW - Interleukin-7/immunology
KW - Lymphocyte Activation/drug effects
KW - Neutrophils/immunology
KW - Signal Transduction
KW - T-Lymphocytes, Helper-Inducer/immunology
U2 - 10.1002/eji.201546203
DO - 10.1002/eji.201546203
M3 - SCORING: Journal article
C2 - 28295230
VL - 47
SP - 900
EP - 910
JO - EUR J IMMUNOL
JF - EUR J IMMUNOL
SN - 0014-2980
IS - 5
ER -